Skip to main content

Myocardial tissue characterization in ischemic heart disease

Neuer Inhalt

Neuer Inhalt (1)


The thematic series “Myocardial tissue characterization in ischemic heart disease” is currently open for further submissions on this topic. The guest editors Professors Akos Varga-Szemes and Prof Pal S. Suranyi (Charleston/US) are looking forward to receiving your contribution.

Ischemic heart disease remains a leading cause of mortality worldwide and an increasing health problem in developed and developing countries alike.

Advanced imaging modalities are increasingly becoming essential tools in the diagnosis and management of ischemic heart disease. Ongoing innovation in radiology research has been leading to the development of safer, faster, and more accurate non-invasive imaging techniques.

This European Radiology Experimental thematic series on “Myocardial tissue characterization in ischemic heart disease” provides an overview of the well-established imaging modalities in ischemic heart disease, alongside recent advances, and ongoing developments in the field.

This series features Professors Akos Varga-Szemes and Pal S. Suranyi (Charleston/US) as guest editors. Their thorough selection of excellent contributing authors and topics enabled the publication of high-quality articles included in this series.

The three review articles of the series illustrate the emerging methods for non-invasive characterisation of ischemic heart disease (M. Willemink et al), and the currently clinically available CT (M. van Assen et al), and state-of-the-art MRI (T. Emrich et al) techniques for myocardial tissue characterisation. Finally, the original article by C. B. Monti et al investigates the impact of gadolinium-based contrast agent dosing on image quality in patients with myocardial infarction. 

This thematic series is also accompanied by a compelling editorial written by our expert guest editors, underlining the relevance of the articles included in this series and illustrates the crucial role of various imaging modalities in the current clinical workup of ischemic heart disease.

  1. Ischemic heart disease and its sequelae are one of the major contributors to morbidity and mortality worldwide. Over the last decades, technological developments have strengthened the role of noninvasive imagi...

    Authors: Tilman Emrich, Moritz Halfmann, U. Joseph Schoepf and Karl-Friedrich Kreitner
    Citation: European Radiology Experimental 2021 5:14
  2. After an ischemic event, disruptive changes in the healthy myocardium may gradually develop and may ultimately turn into fibrotic scar. While these structural changes have been described by conventional imagin...

    Authors: Martin J. Willemink, Akos Varga-Szemes, U. Joseph Schoepf, Marina Codari, Koen Nieman, Dominik Fleischmann and Domenico Mastrodicasa
    Citation: European Radiology Experimental 2021 5:12
  3. This review provides an overview of the currently available computed tomography (CT) techniques for myocardial tissue characterization in ischemic heart disease, including CT perfusion and late iodine enhancem...

    Authors: M. van Assen, M. Vonder, G. J. Pelgrim, P. L. Von Knebel Doeberitz and R. Vliegenthart
    Citation: European Radiology Experimental 2020 4:36
  4. Contrast-enhanced cardiac magnetic resonance (CMR) is pivotal for evaluating chronic myocardial infarction (CMI). Concerns about safety of gadolinium-based contrast agents favour dose reduction. We assessed im...

    Authors: Caterina Beatrice Monti, Marina Codari, Andrea Cozzi, Marco Alì, Lorenzo Saggiante, Francesco Sardanelli and Francesco Secchi
    Citation: European Radiology Experimental 2020 4:21